| Literature DB >> 15087383 |
Elise Schmitt1, Arnaud Parcellier, François Ghiringhelli, Noelia Casares, Sandeep Gurbuxani, Nathalie Droin, Ahmed Hamai, Marie Pequignot, Arlette Hammann, Monique Moutet, Annie Fromentin, Guido Kroemer, Eric Solary, Carmen Garrido.
Abstract
We and others have previously reported in an in vivo rat colon cancer cell model that cell death precedes and is necessary for the development of a specific antitumoral immune response. To sensitize colon cancer cells to death, we depleted cytochrome c by stable transfection with an antisense construct. Cytochrome c depletion sensitizes human and rat colon cancer cells to a nonapoptotic, nonautophagic death induced by various stimuli. This increased sensitization to a necrosis-like cell death may be related to a decrease in cellular ATP levels and an increase in reactive oxygen species production caused by cytochrome c depletion. In vivo, depletion of cytochrome c decreases the tumorigenicity of colon cancer cells in syngeneic rats without influencing their growth in immune-deficient animals. Furthermore, decreased expression of cytochrome c in tumor cells facilitates in vivo "necrotic" cell death and the induction of a specific immune response. These results delineate a novel strategy to sensitize colon cancer cells to chemotherapy and to increase their immunogenicity in immuno-competent hosts.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15087383 DOI: 10.1158/0008-5472.can-03-2475
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701